At 4‐5 years after diagnosis, 93.9% required insulin for management of their hyperglycaemia, 21.2% had hypertension requiring treatment, 28.6% had low‐density lipoprotein ≥130 mg/dL, and 28.6% had high‐density lipoprotein <40 mg/dL. The gene discussed is INS; the disease is hypertensive disorder.